| Codeine intoxication associated with ultrarapid CYP2D6 metabolism Y Gasche, Y Daali, M Fathi, A Chiappe, S Cottini, P Dayer, J Desmeules New England Journal of Medicine 351 (27), 2827-2831, 2004 | 811 | 2004 |
| Neurophysiologic evidence for a central sensitization in patients with fibromyalgia JA Desmeules, C Cedraschi, E Rapiti, E Baumgartner, A Finckh, P Cohen, ... Arthritis & Rheumatism 48 (5), 1420-1429, 2003 | 733 | 2003 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 500 | 2016 |
| Applications of CYP450 testing in the clinical setting CF Samer, KI Lorenzini, V Rollason, Y Daali, JA Desmeules Molecular diagnosis & therapy 17, 165-184, 2013 | 454 | 2013 |
| The pharmacology of tramadol P Dayer, J Desmeules, L Collart Drugs 53, 18-24, 1997 | 442 | 1997 |
| The pharmacology of tramadol P Dayer, L Collart, J Desmeules Drugs 47, 3-7, 1994 | 375 | 1994 |
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial A Huttner, JA Dayer, S Yerly, C Combescure, F Auderset, J Desmeules, ... The Lancet Infectious Diseases 15 (10), 1156-1166, 2015 | 313 | 2015 |
| Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management C Cedraschi, J Desmeules, E Rapiti, E Baumgartner, P Cohen, A Finckh, ... Annals of the rheumatic diseases 63 (3), 290-296, 2004 | 311 | 2004 |
| Contribution of monoaminergic modulation to the analgesic effect of tramadol JA Desmeules, V Piguet, L Collart, P Dayer British journal of clinical pharmacology 41 (1), 7-12, 1996 | 295 | 1996 |
| Impact of environmental and genetic factors on codeine analgesia J Desmeules, MP Gascon, P Dayer, M Magistris European journal of clinical pharmacology 41, 23-26, 1991 | 291 | 1991 |
| Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors GB Ehret, C Voide, M Gex-Fabry, J Chabert, D Shah, B Broers, V Piguet, ... Archives of internal medicine 166 (12), 1280-1287, 2006 | 276 | 2006 |
| Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI) P Dayer, J Desmeules, T Leemann, R Striberni Biochemical and biophysical research communications 152 (1), 411-416, 1988 | 259 | 1988 |
| CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis N Vuilleumier, MF Rossier, A Chiappe, F Degoumois, P Dayer, ... European journal of clinical pharmacology 62, 423-429, 2006 | 257 | 2006 |
| Hepatitis associated with Kava, a herbal remedy for anxiety M Escher, J Desmeules, E Giostra, G Mentha Bmj 322 (7279), 139, 2001 | 252 | 2001 |
| Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trial C Czarnetzki, N Elia, C Lysakowski, L Dumont, BN Landis, R Giger, ... Jama 300 (22), 2621-2630, 2008 | 239 | 2008 |
| Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety CF Samer, Y Daali, M Wagner, G Hopfgartner, CB Eap, MC Rebsamen, ... British journal of pharmacology 160 (4), 919-930, 2010 | 228 | 2010 |
| Analgesics in patients with hepatic impairment: pharmacology and clinical implications M Bosilkovska, B Walder, M Besson, Y Daali, J Desmeules Drugs 72, 1645-1669, 2012 | 221 | 2012 |
| The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone CF Samer, Y Daali, M Wagner, G Hopfgartner, CB Eap, MC Rebsamen, ... British journal of pharmacology 160 (4), 907-918, 2010 | 184 | 2010 |
| Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital K Ing-Lorenzini, J Desmeules, O Plachta, D Suva, P Dayer, R Peter Drug Safety 32, 775-785, 2009 | 171 | 2009 |
| The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction MC Rebsamen, J Desmeules, Y Daali, A Chiappe, A Diemand, C Rey, ... The pharmacogenomics journal 9 (1), 34-41, 2009 | 150 | 2009 |
Pascal BonnabryGeneva University HospitalsVerified email at hcuge.ch
